TNF and ulcerative colitis: Evidence on combined IL-1 and TNF-α inhibition remains limited.<h4>Cases</h4>A 15-year-old girl with ulcerative colitis and recurrent pericarditis received adalimumab and anakinra, achieving clinical remission without infections over eight months.